Compare IRMD & GSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IRMD | GSBD |
|---|---|---|
| Founded | 1992 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 974.8M |
| IPO Year | 2014 | 2013 |
| Metric | IRMD | GSBD |
|---|---|---|
| Price | $87.61 | $10.13 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 1 | 2 |
| Target Price | ★ $116.00 | $9.00 |
| AVG Volume (30 Days) | 108.2K | ★ 977.3K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | 0.95% | ★ 13.49% |
| EPS Growth | 16.67 | ★ 87.27 |
| EPS | ★ 0.86 | 0.09 |
| Revenue | ★ $83,814,000.00 | N/A |
| Revenue This Year | $12.38 | N/A |
| Revenue Next Year | $11.31 | N/A |
| P/E Ratio | ★ $101.16 | $112.56 |
| Revenue Growth | ★ 14.43 | N/A |
| 52 Week Low | $67.84 | $8.36 |
| 52 Week High | $107.90 | $11.53 |
| Indicator | IRMD | GSBD |
|---|---|---|
| Relative Strength Index (RSI) | 41.27 | 67.85 |
| Support Level | $84.05 | $8.96 |
| Resistance Level | $88.72 | $10.24 |
| Average True Range (ATR) | 2.33 | 0.16 |
| MACD | 0.09 | 0.03 |
| Stochastic Oscillator | 32.47 | 97.06 |
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
Goldman Sachs BDC Inc is a non-diversified, closed-end management investment company that elected to be regulated as a business development company focused on lending to middle-market companies. The investment objective is to generate current income and, to a lesser extent, capital appreciation through direct originations of secured debt, including the first lien, unitranche and second lien debt, and unsecured debt. It invests in U.S. middle-market companies such as banks and the public debt markets. The company focuses on the negotiation and structuring of the loans or securities in which it invests and holding the investments in its portfolio to maturity. It generates majority revenue in the form of interest income and dividend income.